Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-202-6 | CAS number: 1313-13-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro studies
a- bacterial test
As reported in SIDS Dossier of MnO2 approved at SIAM 25 (17 -18 October 2007) with reference to unpublish report National Institute of Environmental Research (NIER), Korea, 2006, In vitro bacterial reverse mutation test of manganese dioxide (Report No. G01-06044) tested by Medvill Bacterial reverse mutation test (Ames test) is negative regarding to manganese dioxide in both the presence and absence of a metabolising system. Cytotoxicity was observed at 1250 and 5000 µg/plate in the TA 100 without metabolic activation. The precipitation of test substance was observed at 1250 and 5000 µg/plate regardless of S9 mix. In this study, Salmonella typhimurium strains TA100, TA1535, TA98 and TA1537 andEscherichia coli strain WP2uvrA were tested at six concentrations up to 1250 µg/plate with and without metabolic activation. All of the positive controls in the presence and absence of S9 mix induced marked increases in the frequency of revertant colonies. Manganese dioxide was not mutagenic in both the presence and absence of a metabolising system.
b- non-bacterial test
A different result about manganese dioxide genotoxicity compared to AMES test was reported in SIDS Dossier of MnO2 approved at SIAM 25 (17 -18 October 2007) with reference to unpublish report National Institute of Environmental Research (NIER), Korea, 2006,In vitro mammalian chromosome aberration test of manganese dioxide (Report No. G02-06035), tested by Medvill.The Chinese hamster lung cells were treated continuously (24 hours) in the absence of metabolic activation and shortly (6 hours) in the presence or absence of metabolic activation with manganese dioxide at the concentrations of 0, 217.4, 434.7, 869.4 µg/ml (limited concentration, 10 mM). In the long-term test, all concentrations significantly induced the frequency of aberrant cells. Structural chromosomal aberrations and polyploidy were not induced up to 869.4µg/ml either with or without metabolic activation in the short-term test. The numbers of structural chromosome aberration cells of positive control were significantly increased as compared with those of a negative control. Manganese dioxide showed clastogenic potential in the long-term test.
In vivo studies
The potential genotoxicity of manganese dioxide appears to be confirmed from in vivo test micronucleus assay on mice reported inSIDS Dossier of MnO2 approved at SIAM 25 (17 -18 October 2007) with reference to National Institute of Environmental Research(NIER), Korea, 2007,In vivo micronucleus test of Manganese dioxide in male ICR mice (Report No. 07-GTT-MNT-002), tested by Center for Biosafety Catholic Univ. of Daegu. 0.5% Carboxymethylcellulose and mitomycin C (0.5 mg/kg bw) were used as a negative control and positive control, respectively. Groups of 5 male mice were orally administered manganese dioxide at the dose levels of 500, 1,000, and 2,000 mg/kg bw for 24, 48 and 72 hours. All animals dosed with manganese dioxide exhibited similar PCE/(PCE + NCE) ratios compare to those of negative control animals. The MNPCE frequencies (%) of manganese dioxide (2000 mg/kg) treated animals is significantly increased (p < 0.05). All frequencies of MNPCE in negative control groups fell within acceptable ranges, while the positive control group induced clear increases in the frequencies of MNPCE.
Conclusion
Based on these results, manganese dioxide was not mutagenic in bacteria either with or without metabolic activation, but induced chromosomal aberrations in mammalian cellsin vitro. In addition, manganese dioxide did induce micronuclei in the mice bone marrow cellsin vivo. The available information suggests that manganese dioxide is genotoxic but no enough data are available to classified the substance. Moreover, MnO2 is not classified for genetic toxicity according to annex VI of CLP Regulation (EC n.1272/2008).
Short description of key information:
Available in vitro and in vivo study for genetic toxicity, some with potential concern but insufficent for classification.
Endpoint Conclusion: Adverse effect observed (positive)
Justification for classification or non-classification
Based on these results, manganese dioxide was not mutagenic in bacteria either with or without metabolic activation, but induced chromosomal aberrations in mammalian cells in vitro. In addition, manganese dioxide did induce micronuclei in the mice bone marrow cells in vivo. The available information suggests that manganese dioxide is genotoxic but no enough data are available to classified the substance.
Moreover, MnO2 is not classified for genetic toxicity according to annex VI of CLP Regulation (EC n.1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.